Facebook puts label on Trump post, Pfizer/BioNTech to supply U.S. up to 600M COVID vaccine doses, and more.

BeiGene, a Beijing oncology drug biopharma, announced a $2.1 billion private placement that will bring its cash holdings to almost $5.5 billion The company is developing a portfolio of 25 candidates, with several of them in Phase III tests.

Europe points to a strong start boosted by coronavirus treatment hopes and cautious optimism ahead of US earning season, which kicks off this week.

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap.

Friday was a risk-off day for biotech stocks as the XBI​ took a 3.28% hit on profit taking and concerns that the pandemic could drag on through the summer.